Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Federal Trade Commission
Citi
UBS
Fuji
McKesson
Johnson and Johnson
Queensland Health
Moodys
Argus Health

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,468,755

« Back to Dashboard

Summary for Patent: 5,468,755
Title: Therapeutic process for the treatment of the pathologies of Type II diabetes
Abstract:A process for the long term modification and regulation of lipid and carbohydrate metabolism--generally to reduce obesity, insulin resistance, and hyperinsulinemia or hyperglycemia, or both (these are the hallmarks of noninsulin dependent, or Type II diabetes)--by administration (i.e., by oral, sublingual or parenternal administration) to a vertebrate, animal or human, of a dopamine agonist, e.g., bromocriptine. Administration of the bromocriptine is made over a limited period at a time of day dependent on the normal circadian rhythm of insulin resistant and insulin sensitive members of a similar species. Insulin resistance, and hyperinsulinemia and hyperglycemia, or both, can be controlled in humans on a long term basis by such treatment inasmuch as the short term daily administration resets hormonal timing in the neural centers of the brain to produce long term effects.
Inventor(s): Cincotta; Anthony H. (Andover, MA), Meier; Albert H. (Baton Rouge, LA)
Assignee: The Board of Supervisors of Louisiana State University and Agricultural (Baton Rouge, LA)
Application Number:08/158,153
Patent Claim Types:
see list of patent claims
Use; Compound;

Drugs Protected by US Patent 5,468,755

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,468,755

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 174793 ➤ Sign Up
Austria 227566 ➤ Sign Up
Austria 249216 ➤ Sign Up
Austria 290863 ➤ Sign Up
Austria 391506 ➤ Sign Up
Austria 440606 ➤ Sign Up
Australia 1447595 ➤ Sign Up
Australia 1569395 ➤ Sign Up
Australia 2259092 ➤ Sign Up
Australia 3101395 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Fuji
QuintilesIMS
McKesson
Mallinckrodt
Chubb
Colorcon
Moodys
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot